Additive Effects of Omega-3 Fatty Acids and Thiazolidinediones in Mice Fed a High-Fat Diet: Triacylglycerol/Fatty Acid Cycling in Adipose Tissue

Nutrients - Tập 12 Số 12 - Trang 3737
Kristina Bardová1, Jiří Funda1, Radek Pohl2, Tomáš Čajka3,4, Michal Hensler1, Ondřej Kuda5, Petra Janovská1, Kateřina Adamcová1, Ilaria Irodenko1, Lucie Lenkova1, Petr Zouhar1, Olga Horakova1, Pavel Flachs1, Martin Rossmeisl1, Jerry R. Colca6, Ján Kopecký1
1Laboratory of Adipose Tissue Biology, Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague 4, Czech Republic
2NMR Spectroscopy, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemmingovo Namesti 542/2, 160 00 Prague 6, Czech Republic
3Laboratory of Metabolomics, Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague 4, Czech Republic
4Laboratory of Translational Metabolism, Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic
5Laboratory of Metabolism of Bioactive Lipids, Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague 4, Czech Republic
6Cirius Therapeutics, Kalamazoo, MI 490 07, USA

Tóm tắt

Long-chain n-3 polyunsaturated fatty acids (Omega-3) and anti-diabetic drugs thiazolidinediones (TZDs) exhibit additive effects in counteraction of dietary obesity and associated metabolic dysfunctions in mice. The underlying mechanisms need to be clarified. Here, we aimed to learn whether the futile cycle based on the hydrolysis of triacylglycerol and re-esterification of fatty acids (TAG/FA cycling) in white adipose tissue (WAT) could be involved. We compared Omega-3 (30 mg/g diet) and two different TZDs—pioglitazone (50 mg/g diet) and a second-generation TZD, MSDC-0602K (330 mg/g diet)—regarding their effects in C57BL/6N mice fed an obesogenic high-fat (HF) diet for 8 weeks. The diet was supplemented or not by the tested compound alone or with the two TZDs combined individually with Omega-3. Activity of TAG/FA cycle in WAT was suppressed by the obesogenic HF diet. Additive effects in partial rescue of TAG/FA cycling in WAT were observed with both combined interventions, with a stronger effect of Omega-3 and MSDC-0602K. Our results (i) supported the role of TAG/FA cycling in WAT in the beneficial additive effects of Omega-3 and TZDs on metabolism of diet-induced obese mice, and (ii) showed differential modulation of WAT gene expression and metabolism by the two TZDs, depending also on Omega-3.

Từ khóa


Tài liệu tham khảo

Flachs, 2013, Stimulation of mitochondrial oxidative capacity in white fat independent of UCP1: A key to lean phenotype, Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids, 1831, 986

Masoodi, 2015, Lipid signaling in adipose tissue: Connecting inflammation & metabolism, Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids, 1851, 503

Kuda, 2018, Omega-3 fatty acids and adipose tissue biology, Mol. Asp. Med., 64, 147, 10.1016/j.mam.2018.01.004

Lai, 2018, Serial circulating omega 3 polyunsaturated fatty acids and healthy ageing among older adults in the Cardiovascular Health Study: Prospective cohort study, BMJ, 363, k4067, 10.1136/bmj.k4067

Manson, 2018, Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer, N. Engl. J. Med., 380, 23, 10.1056/NEJMoa1811403

Flachs, 2011, Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids, Diabetologia, 54, 2626, 10.1007/s00125-011-2233-2

Rossmeisl, 2014, Omega-3 phospholipids from fish suppress hepatic steatosis by integrated inhibition of biosynthetic pathways in dietary obese mice, Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids, 1841, 267

Calder, 2018, Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids, Clin. Nutr., 37, 37, 10.1016/j.clnu.2017.01.006

Flachs, 2006, Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed high-fat diet, Diabetologia, 49, 394, 10.1007/s00125-005-0053-y

Wu, 2013, Effect of fish oil on circulating adiponectin: A systematic review and meta-analysis of randomized controlled trials, J. Clin. Endocrinol. Metab., 98, 2451, 10.1210/jc.2012-3899

Calder, 2015, Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance, Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids, 1851, 469

van Schothorst, E.M., Flachs, P., Franssen-van Hal, N.L., Kuda, O., Bunschoten, A., Molthoff, J., Vink, C., Hooiveld, G.J., Kopecky, J., and Keijer, J. (2009). Induction of lipid oxidation by polyunsaturated fatty acids of marine origin in small intestine of mice fed a high-fat diet. BMC Genom., 10.

Kroupova, P., van Schothorst, E.M., Keijer, J., Bunschoten, A., Vodicka, M., Irodenko, I., Oseeva, M., Zacek, P., Kopecky, J., and Rossmeisl, M. (2020). Omega-3 Phospholipids from Krill Oil Enhance Intestinal Fatty Acid Oxidation More Effectively than Omega-3 Triacylglycerols in High-Fat Diet-Fed Obese Mice. Nutrients, 12.

Ruzickova, 2004, Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue, Lipids, 39, 1177, 10.1007/s11745-004-1345-9

Adamcova, K., Horakova, O., Bardova, K., Janovska, P., Brezinova, M., Kuda, O., Rossmeisl, M., and Kopecky, J. (2018). Reduced Number of Adipose Lineage and Endothelial Cells in Epididymal fat in Response to Omega-3 PUFA in Mice Fed High-Fat Diet. Mar. Drugs, 16.

Kunesova, 2006, The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women, Physiol. Res., 55, 63, 10.33549/physiolres.930770

Mori, 1999, Dietary fish as a major component of a weight-loss diet: Effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects, Am. J. Clin. Nutr., 70, 817, 10.1093/ajcn/70.5.817

Flachs, P., Rossmeisl, M., and Kopecky, J. (2014). The Effect of n-3 Fatty Acids on Glucose Homeostasis and Insulin Sensivity. Physiol. Res., 93–118.

Kuda, 2009, n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet, Diabetologia, 52, 941, 10.1007/s00125-009-1305-z

Kus, 2011, Unmasking Differential Effects of Rosiglitazone and Pioglitazone in the Combination Treatment with n-3 Fatty Acids in Mice Fed a High-Fat Diet, PLoS ONE, 6, e27126, 10.1371/journal.pone.0027126

Choi, 2010, Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5, Nature, 466, 451, 10.1038/nature09291

Divakaruni, 2013, Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier, Proc. Natl. Acad. Sci. USA, 110, 5422, 10.1073/pnas.1303360110

Colca, J.R., McDonald, W.G., Cavey, G.S., Cole, S.L., Holewa, D.D., Brightwell-Conrad, A.S., Wolfe, C.L., Wheeler, J.S., Coulter, K.R., and Kilkuskie, P.M. (2013). Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT)--relationship to newly identified mitochondrial pyruvate carrier proteins. PLoS ONE, 8.

Wang, 2016, PPARgamma signaling and emerging opportunities for improved therapeutics, Pharmacol. Res., 111, 76, 10.1016/j.phrs.2016.02.028

Chen, 2012, Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor gamma-sparing thiazolidinedione, J. Biol. Chem., 287, 23537, 10.1074/jbc.M112.363960

McCommis, 2017, Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis, Hepatology, 65, 1543, 10.1002/hep.29025

Colca, 2014, Insulin sensitizers in 2013: New insights for the development of novel therapeutic agents to treat metabolic diseases, Expert. Opin. Investig. Drugs, 23, 1, 10.1517/13543784.2013.839659

Harrison, 2020, Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study, J. Hepatol., 72, 613, 10.1016/j.jhep.2019.10.023

Reshef, 2003, Glyceroneogenesis and the triglyceride/fatty acid cycle, J. Biol. Chem., 278, 30413, 10.1074/jbc.R300017200

Newsholme, 1976, Substrate cycles: Their metabolic energy and thermic consequences in man, Biochem. Soc. Symp., 43, 183

Hui, 2020, Quantitative Fluxomics of Circulating Metabolites, Cell. Metab., 32, 676, 10.1016/j.cmet.2020.07.013

Kalderon, 2000, Fatty acid cycling in the fasting rat, Am. J. Physiol. Endocrinol. Metab., 279, E221, 10.1152/ajpendo.2000.279.1.E221

Flachs, 2017, Induction of lipogenesis in white fat during cold exposure in mice: Link to lean phenotype, Int. J. Obes., 41, 372, 10.1038/ijo.2016.228

Bederman, 2009, Triglyceride synthesis in epididymal adipose tissue: Contribution of glucose and non-glucose carbon sources, J. Biol. Chem., 284, 6101, 10.1074/jbc.M808668200

Cadoudal, 2008, Pyruvate dehydrogenase kinase 4: Regulation by thiazolidinediones and implication in glyceroneogenesis in adipose tissue, Diabetes, 57, 2272, 10.2337/db08-0477

Flachs, 2005, Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat, Diabetologia, 48, 2365, 10.1007/s00125-005-1944-7

Janovska, 2013, Anti-obesity effect of n-3 polyunsaturated fatty acids in mice fed high-fat diet is independent of cold-induced thermogenesis, Physiol. Res., 62, 153, 10.33549/physiolres.932464

Tordjman, 2003, Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells3, J. Biol. Chem., 278, 18785, 10.1074/jbc.M206999200

Horakova, O., Medrikova, D., van Schothorst, E.M., Bunschoten, A., Flachs, P., Kus, V., Kuda, O., Bardova, K., Janovska, P., and Hensler, M. (2012). Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese mice. PLoS ONE, 7.

Veleba, 2015, Combined intervention with pioglitazone and -3 fatty acids in metformin-treated type 2 diabetic patients: Improvement of lipid metabolism, Nutr. Metab., 12, 52, 10.1186/s12986-015-0047-9

Fukunaga, 2015, An insulin-sensitizing thiazolidinedione, which minimally activates PPARgamma, does not cause bone loss, J. Bone Miner. Res., 30, 481, 10.1002/jbmr.2364

Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262

Kuda, 2016, Docosahexaenoic Acid-Derived Fatty Acid Esters of Hydroxy Fatty Acids (FAHFAs) With Anti-inflammatory Properties, Diabetes, 65, 2580, 10.2337/db16-0385

Xia, 2016, Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis, Curr. Protoc. Bioinform., 55, 14.10.1, 10.1002/cpbi.11

Cinti, 2005, Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans, J. Lipid Res., 46, 2347, 10.1194/jlr.M500294-JLR200

Paton, 2008, Biochemical and Physiological Function of Stearoyl-CoA Desaturase, Am. J. Physiol. Endocrinol. Metab., 297, E28, 10.1152/ajpendo.90897.2008

Kuda, 2009, Prominent role of liver in elevated plasma palmitooleate levels in response to rosiglitazone in mice fed high-fat diet, J. Physiol. Pharmacol., 60, 135

Yen, 2008, Thematic review series: Glycerolipids. DGAT enzymes and triacylglycerol biosynthesis, J. Lipid Res., 49, 2283, 10.1194/jlr.R800018-JLR200

Buresova, 2020, Postnatal induction of muscle fatty acid oxidation in mice differing in propensity to obesity: A role of pyruvate dehydrogenase, Int. J. Obes., 44, 235, 10.1038/s41366-018-0281-0

Seiler, 2015, Carnitine Acetyltransferase Mitigates Metabolic Inertia and Muscle Fatigue during Exercise, Cell Metab., 22, 65, 10.1016/j.cmet.2015.06.003

Bender, 2016, The mitochondrial pyruvate carrier in health and disease: To carry or not to carry?, Biochim. Biophys. Acta (BBA) Mol. Cell Res., 1863, 2436, 10.1016/j.bbamcr.2016.01.017

Herman, 2010, Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels, J. Biol. Chem., 285, 11348, 10.1074/jbc.M109.075184

Newgard, 2009, A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance, Cell Metab., 9, 311, 10.1016/j.cmet.2009.02.002

Hsiao, 2011, Multi-tissue, selective PPARgamma modulation of insulin sensitivity and metabolic pathways in obese rats, Am. J. Physiol. Endocrinol. Metab., 300, E164, 10.1152/ajpendo.00219.2010

Duarte, 2014, A high-fat diet suppresses de novo lipogenesis and desaturation but not elongation and triglyceride synthesis in mice, J. Lipid Res., 55, 2541, 10.1194/jlr.M052308

Ranganathan, 2006, The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: Effects of obesity, insulin resistance, and TZD treatment, J. Lipid Res., 47, 2444, 10.1194/jlr.M600248-JLR200

Adamson, 2006, Polyunsaturated fatty acid suppression of fatty acid synthase (FASN): Evidence for dietary modulation of NF-Y binding to the Fasn promoter by SREBP-1c, J. Lipid Res., 47, 2444

Sanderson, L.M., de Groot, P.J., Hooiveld, G.J., Koppen, A., Kalkhoven, E., Muller, M., and Kersten, S. (2008). Effect of synthetic dietary triglycerides: A novel research paradigm for nutrigenomics. PLoS ONE, 3.

Pavlisova, 2016, Corn oil versus lard: Metabolic effects of omega-3 fatty acids in mice fed obesogenic diets with different fatty acid composition, Biochimie, 124, 150, 10.1016/j.biochi.2015.07.001

Virtue, 2010, Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective, Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids, 1801, 338

Ryden, 2013, Adipocyte triglyceride turnover and lipolysis in lean and overweight subjects, J. Lipid Res., 54, 2909, 10.1194/jlr.M040345

Allister, 2015, In vivo 2H2O administration reveals impaired triglyceride storage in adipose tissue of insulin-resistant humans, J. Lipid Res., 56, 435, 10.1194/jlr.M052860

Hallgren, 1989, Influence of age, fat cell weight, and obesity on O2 consumption of human adipose tissue, Am. J. Physiol., 256, E467

Bernlohr, 2014, Exercise and mitochondrial function in adipose biology: All roads lead to NO, Diabetes, 63, 2606, 10.2337/db14-0638

Nair, 2016, A simple practice guide for dose conversion between animals and human, J. Basic Clin. Pharm., 7, 27, 10.4103/0976-0105.177703